Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 148

1.

Failure-to-rescue in patients undergoing surgery for esophageal or gastric cancer.

Busweiler LA, Henneman D, Dikken JL, Fiocco M, van Berge Henegouwen MI, Wijnhoven BP, van Hillegersberg R, Rosman C, Wouters MW, van Sandick JW; Dutch Upper GI Cancer Audit group.

Eur J Surg Oncol. 2017 Jul 29. pii: S0748-7983(17)30589-9. doi: 10.1016/j.ejso.2017.07.005. [Epub ahead of print]

PMID:
28797755
2.

Defining Benchmarks for Transthoracic Esophagectomy: A Multicenter Analysis of Total Minimally Invasive Esophagectomy in Low Risk Patients.

Schmidt HM, Gisbertz SS, Moons J, Rouvelas I, Kauppi J, Brown A, Asti E, Luyer M, Lagarde SM, Berlth F, Philippron A, Bruns C, Hölscher A, Schneider PM, Raptis DA, Henegouwen MIVB, Nafteux P, Nilsson M, Räsanen J, Palazzo F, Rosato E, Mercer S, Bonavina L, Nieuwenhuijzen G, Wijnhoven BPL, Schröder W, Pattyn P, Grimminger PP, Gutschow CA.

Ann Surg. 2017 Aug 7. doi: 10.1097/SLA.0000000000002445. [Epub ahead of print]

PMID:
28796646
3.

A Propensity Score Matched Analysis of Open Versus Minimally Invasive Transthoracic Esophagectomy in the Netherlands.

Seesing MFJ, Gisbertz SS, Goense L, van Hillegersberg R, Kroon HM, Lagarde SM, Ruurda JP, Slaman AE, van Berge Henegouwen MI, Wijnhoven BPL.

Ann Surg. 2017 Aug 8. doi: 10.1097/SLA.0000000000002393. [Epub ahead of print]

PMID:
28796016
4.

Comparison of Postoperative Outcomes Between Donation After Circulatory Death and Donation After Brain Death Liver Transplantation Using the Comprehensive Complication Index.

Kalisvaart M, de Haan JE, Polak WG, Metselaar HJ, Wijnhoven BPL, IJzermans JNM, de Jonge J.

Ann Surg. 2017 Jul 24. doi: 10.1097/SLA.0000000000002419. [Epub ahead of print]

PMID:
28742700
5.

Describing Peripancreatic Collections According to the Revised Atlanta Classification of Acute Pancreatitis: An International Interobserver Agreement Study.

Bouwense SA, van Brunschot S, van Santvoort HC, Besselink MG, Bollen TL, Bakker OJ, Banks PA, Boermeester MA, Cappendijk VC, Carter R, Charnley R, van Eijck CH, Freeny PC, Hermans JJ, Hough DM, Johnson CD, Laméris JS, Lerch MM, Mayerle J, Mortele KJ, Sarr MG, Stedman B, Vege SS, Werner J, Dijkgraaf MG, Gooszen HG, Horvath KD; Acute Pancreatitis Interobserver Study Group.

Pancreas. 2017 Aug;46(7):850-857. doi: 10.1097/MPA.0000000000000863.

PMID:
28697123
6.

Loss of SRY-box2 (SOX2) expression and its impact on survival of patients with oesophageal adenocarcinoma.

Ten Kate FJC, van Olphen SH, Bruno MJ, Wijnhoven BPL, van Lanschot JJB, Looijenga LHJ, Fitzgerald RC, Biermann K.

Br J Surg. 2017 Sep;104(10):1327-1337. doi: 10.1002/bjs.10553. Epub 2017 Jul 10.

PMID:
28692180
7.

Exploring diagnostic and therapeutic implications of endoscopic mucosal resection in EUS-staged T2 esophageal adenocarcinoma.

Gotink AW, Spaander MCW, Doukas M, Tang TJ, Didden P, Wijnhoven BPL, Bruno MJ, Koch AD.

Endoscopy. 2017 Jun 21. doi: 10.1055/s-0043-112492. [Epub ahead of print]

PMID:
28637063
8.

Molecular clonality analysis of esophageal adenocarcinoma by multiregion sequencing of tumor samples.

van Nistelrooij AM, van Marion R, Koppert LB, Biermann K, Spaander MC, Tilanus HW, van Lanschot JJ, Wijnhoven BP, Dinjens WN.

BMC Res Notes. 2017 Apr 4;10(1):144. doi: 10.1186/s13104-017-2456-5.

9.

Impact of Surgical Approach on Long-term Survival in Esophageal Adenocarcinoma Patients With or Without Neoadjuvant Chemoradiotherapy.

Noordman BJ, van Klaveren D, van Berge Henegouwen MI, Wijnhoven BP, Gisbertz SS, Lagarde SM, van der Gaast A, Hulshof MC, Biermann K, Steyerberg EW, van Lanschot JJ; also on behalf of the CROSS-study group.

Ann Surg. 2017 Mar 27. doi: 10.1097/SLA.0000000000002240. [Epub ahead of print]

PMID:
28350565
10.

Reply to "Neoadjuvant Therapy and Lymphadenectomy in Esophageal Cancer: Both Are Essential to Maximize Survival Benefit".

Talsma AK, Wijnhoven BP, Steyerberg EW, van Lanschot JJ.

Ann Surg. 2017 Apr;265(4):e42-e43. doi: 10.1097/SLA.0000000000001197. No abstract available.

PMID:
28266983
11.

Textbook outcome as a composite measure in oesophagogastric cancer surgery.

Busweiler LA, Schouwenburg MG, van Berge Henegouwen MI, Kolfschoten NE, de Jong PC, Rozema T, Wijnhoven BP, van Hillegersberg R, Wouters MW, van Sandick JW; Dutch Upper Gastrointestinal Cancer Audit (DUCA) group.

Br J Surg. 2017 May;104(6):742-750. doi: 10.1002/bjs.10486. Epub 2017 Feb 27.

PMID:
28240357
12.

Prognostic Value of Pretreatment Pathological Tumor Extent in Patients Treated With Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal or Junctional Cancer.

Shapiro J, Biermann K, van Klaveren D, Offerhaus GJ, Ten Kate FJ, Meijer SL, van Berge Henegouwen MI, Steyerberg EW, Wijnhoven BP, Lanschot JJ.

Ann Surg. 2017 Feb;265(2):356-362. doi: 10.1097/SLA.0000000000001630.

PMID:
28059964
13.

P53 and SOX2 Protein Expression Predicts Esophageal Adenocarcinoma in Response to Neoadjuvant Chemoradiotherapy.

van Olphen SH, Biermann K, Shapiro J, Wijnhoven BP, Toxopeus EL, van der Gaast A, Stoop HA, van Lanschot JJ, Spaander MC, Bruno MJ, Looijenga LH.

Ann Surg. 2017 Feb;265(2):347-355. doi: 10.1097/SLA.0000000000001625.

PMID:
28059963
14.

Multimodality treatment for esophageal adenocarcinoma: multi-center propensity-score matched study.

Markar SR, Noordman BJ, Mackenzie H, Findlay JM, Boshier PR, Ni M, Steyerberg EW, van der Gaast A, Hulshof MCCM, Maynard N, van Berge Henegouwen MI, Wijnhoven BPL, Reynolds JV, Van Lanschot JJB, Hanna GB.

Ann Oncol. 2017 Mar 1;28(3):519-527. doi: 10.1093/annonc/mdw560.

15.

Recommendations for pathologic staging (pTNM) of cancer of the esophagus and esophagogastric junction for the 8th edition AJCC/UICC staging manuals.

Rice TW, Ishwaran H, Hofstetter WL, Kelsen DP, Apperson-Hansen C, Blackstone EH; Worldwide Esophageal Cancer Collaboration Investigators.

Dis Esophagus. 2016 Nov;29(8):897-905. doi: 10.1111/dote.12533.

PMID:
27905172
16.

Recommendations for clinical staging (cTNM) of cancer of the esophagus and esophagogastric junction for the 8th edition AJCC/UICC staging manuals.

Rice TW, Ishwaran H, Blackstone EH, Hofstetter WL, Kelsen DP, Apperson-Hansen C; Worldwide Esophageal Cancer Collaboration Investigators.

Dis Esophagus. 2016 Nov;29(8):913-919. doi: 10.1111/dote.12540.

PMID:
27905171
17.

Recommendations for neoadjuvant pathologic staging (ypTNM) of cancer of the esophagus and esophagogastric junction for the 8th edition AJCC/UICC staging manuals.

Rice TW, Ishwaran H, Kelsen DP, Hofstetter WL, Apperson-Hansen C, Blackstone EH; Worldwide Esophageal Cancer Collaboration Investigators.

Dis Esophagus. 2016 Nov;29(8):906-912. doi: 10.1111/dote.12538.

PMID:
27905170
18.

Does Routine Endoscopy or Contrast Swallow Study After Esophagectomy and Gastric Tube Reconstruction Change Patient Management?

Nederlof N, de Jonge J, de Vringer T, Tran TC, Spaander MC, Tilanus HW, Wijnhoven BP.

J Gastrointest Surg. 2017 Feb;21(2):251-258. doi: 10.1007/s11605-016-3268-y. Epub 2016 Nov 14.

19.

Sarcopenia/Muscle Mass is not a Prognostic Factor for Short- and Long-Term Outcome After Esophagectomy for Cancer.

Grotenhuis BA, Shapiro J, van Adrichem S, de Vries M, Koek M, Wijnhoven BP, van Lanschot JJ.

World J Surg. 2016 Nov;40(11):2698-2704.

20.

Worldwide Esophageal Cancer Collaboration: clinical staging data.

Rice TW, Apperson-Hansen C, DiPaola LM, Semple ME, Lerut TE, Orringer MB, Chen LQ, Hofstetter WL, Smithers BM, Rusch VW, Wijnhoven BP, Chen KN, Davies AR, D'Journo XB, Kesler KA, Luketich JD, Ferguson MK, Räsänen JV, van Hillegersberg R, Fang W, Durand L, Allum WH, Cecconello I, Cerfolio RJ, Pera M, Griffin SM, Burger R, Liu JF, Allen MS, Law S, Watson TJ, Darling GE, Scott WJ, Duranceau A, Denlinger CE, Schipper PH, Ishwaran H, Blackstone EH.

Dis Esophagus. 2016 Oct;29(7):707-714. doi: 10.1111/dote.12493.

PMID:
27731549

Supplemental Content

Loading ...
Support Center